Biology Talk

rpautrey2 · Guest

Oral Pot Preparation Effective For Depression, Journal Reports

June 26, 2008 - Vienna, Austria

Vienna, Austria: Oral administration of synthetic THC capsules
(dronabinol) mitigates symptoms of depression in patients seeking
clinical treatment, according to a pair of case studies published in
the June issue of Cannabinoids, the journal of the International
Association for Cannabis as Medicine (IACM, Germany). A general
practitioner in Vienna, Austria reported two cases of patients using
dronabinol to improve depression and a sense of feeling overwhelmed.
For the first patient, a 48-year-old female, dronabinol administered
up to four times daily relieved the severity and frequency of her
chronic depression and improved her quality of life. For the second
patient, a 22-year-old female, daily administration of up to 10mg of
dronabinol was associated with a "significant improvement of her
depressive condition."

Overall, the author reported that 80 percent of the patients he had
treated with dronabinol between 2003 and 2006 had experienced a "swift
improvement" with oral cannabinoids. "The presented observations
suggest that dronabinol has an antidepressive potential that can
readily be used in medical practice," the author concluded. "To date
no clinical studies have studied primarily the effectiveness of
cannabinoids for the treatment of depression. In my opinion, such
studies are desirable and promising."

For more information, please contact Paul Armentano, NORML Deputy
Director. Full text of the study, "Treating depression with
cannabinoids,"

updated: Jun 26, 2008

© 2008 NORML • Read our Privacy Statement • Site by Communicopia.Net
and Red Aphid

NORML and the NORML Foundation: 1600 K Street NW, Suite 501,
Washington DC, 20006-2832
Tel: (202) 483-5500 • Fax: (202) 483-0057 • Email: norml@norml.org

URL: http://www.norml.org/index.cfm?Group_ID=7631